AMPLE - ABATACEPT VERSUS ADALIMUMAB COMPARISON IN BIOLOGIC-NAIVE RA SUBJECTS WITH BACKGROUND METHOTREXATE Trademark

Trademark Overview

On Tuesday, February 22, 2011, a trademark application was filed for AMPLE - ABATACEPT VERSUS ADALIMUMAB COMPARISON IN BIOLOGIC-NAIVE RA SUBJECTS WITH BACKGROUND METHOTREXATE with the United States Patent and Trademark Office. The USPTO has given the AMPLE - ABATACEPT VERSUS ADALIMUMAB COMPARISON IN BIOLOGIC-NAIVE RA SUBJECTS WITH BACKGROUND METHOTREXATE trademark a serial number of 85248221. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 26, 2013. This trademark is owned by Bristol-Myers Squibb Company. The AMPLE - ABATACEPT VERSUS ADALIMUMAB COMPARISON IN BIOLOGIC-NAIVE RA SUBJECTS WITH BACKGROUND METHOTREXATE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use
ample - abatacept versus adalimumab comparison in biologic-naive ra subjects with background methotrexate

General Information

Serial Number85248221
Word MarkAMPLE - ABATACEPT VERSUS ADALIMUMAB COMPARISON IN BIOLOGIC-NAIVE RA SUBJECTS WITH BACKGROUND METHOTREXATE
Filing DateTuesday, February 22, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 26, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 31, 2011

Trademark Statements

Disclaimer with Predetermined Text"ABATACEPT VERSUS ADALIMUMAB COMPARISON IN BIOLOGIC-NAIVE RA SUBJECTS WITH BACKGROUND METHOTREXATE"
Goods and ServicesMedical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, February 25, 2011
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10154
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Monday, August 26, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 26, 2013ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 12, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 16, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Tuesday, January 15, 2013EXTENSION 3 GRANTED
Friday, January 11, 2013EXTENSION 3 FILED
Friday, January 11, 2013TEAS EXTENSION RECEIVED
Wednesday, July 4, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Tuesday, July 3, 2012EXTENSION 2 GRANTED
Thursday, June 28, 2012EXTENSION 2 FILED
Thursday, June 28, 2012TEAS EXTENSION RECEIVED
Thursday, January 26, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Wednesday, January 25, 2012EXTENSION 1 GRANTED
Thursday, December 22, 2011EXTENSION 1 FILED
Wednesday, January 25, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 22, 2011TEAS EXTENSION RECEIVED
Tuesday, July 26, 2011NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 31, 2011PUBLISHED FOR OPPOSITION
Wednesday, May 11, 2011NOTICE OF PUBLICATION
Thursday, April 28, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, April 28, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 19, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 19, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 20, 2011EXAMINER'S AMENDMENT MAILED
Tuesday, April 19, 2011EXAMINER'S AMENDMENT ENTERED
Tuesday, April 19, 2011ASSIGNED TO LIE
Tuesday, April 19, 2011EXAMINERS AMENDMENT -WRITTEN
Monday, April 18, 2011ASSIGNED TO EXAMINER
Friday, February 25, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, February 25, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

naive subjects background methotrexate biologic comparison abatacept versus adalimumab ample relating pharmaceutical preparations human trials clinical scientific research namely conducting